No registrations found.
ID
Source
Brief title
Health condition
1. Constipation;
2. fecal incontinence;
3. abdominal pain.
Sponsors and support
Intervention
Outcome measures
Primary outcome
1. Defecation frequency;
2. Frequency of faecal incontinence episodes.
Secondary outcome
Abdominal pain.
Background summary
Children presenting at the outpatient clinics of the gastroenterology of the Emma Children's hospital will be randomised to either Forlax or Transipeg as a laxans therapy. The difference between the two agents in success will be evaluated at the end of the study.
Study objective
Forlax and transipeg are equally effective in treating childhood constipation.
Study design
N/A
Intervention
None, because the children would be treated by laxants anyway. For this reason we don't assusme treatment as an intervention.
Department of paediatric gastroenterology
Postbus 22660
N. Bekkali
Amsterdam 1100 DD
The Netherlands
+31-205662906
Department of paediatric gastroenterology
Postbus 22660
N. Bekkali
Amsterdam 1100 DD
The Netherlands
+31-205662906
Inclusion criteria
1. Infants between 6 months and 15 years;
2. Defecation frequency < 3/week;
3. No oral laxatives for 2 weeks;
4. No PEG-laxatives for 2 months.
Exclusion criteria
1. Metabolic disease;
2. functional non-retentive faecal incontinence;
3. mental retardation;
4. cerebral palsy;
5. anal anomalies;
6. Hirschsprung's disease.
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
| Register | ID |
|---|---|
| NTR-new | NL1065 |
| NTR-old | NTR1098 |
| Other | : Transipeg-Forlax studie |
| ISRCTN | ISRCTN wordt niet meer aangevraagd |